Market debut IPO: Tissue Repair Ltd (ASX: TRP)
Tissue Repair Ltd (ASX: TRP) has debuted on the Australian stock exchange today.
Following an IPO at $1.15/share raising $22 million, giving the company a market capitalisation of $70 million, shares in Tissue Repair fell 38.48% to $0.70/share.
Tissue Repair’s Chairman Jack Lowenstein said ‘Completing our IPO and listing on the ASX now gives us the opportunity to pursue a drug label in a chronic wound indication which has significant unmet needs. Therapeutic claims in a chronic wound, if achieved by our Phase III studies, provide a platform for growth and revenue generation with a product that is different to others currently available’.
An increase in listing price is a vote of confidence from the market about the future prospects of the company.
A decrease in the listing price can be interpreted in a number of ways, including whether the IPO was accurately priced.
Read the full story
in the Grafa app
To read the full article and more in the Grafa app, available on all app stores.
Track the trends
Get the hot tips first
Stay close to your investments
Learn to trade like a pro
Let your money entertain you
See more stories like this
48% of businesses say they will not raise prices, primarily due to the desire to...read more